Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Capital Expenditures

Aquestive Therapeutics Inc Capital Expenditures Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Capital Expenditures from 2006 to 2018.
  • Aquestive Therapeutics Inc Capital Expenditures for the quarter ending September 09, 2018 was $0m a 80.36% decrease of 0m year over year
  • Aquestive Therapeutics Inc Capital Expenditures for the last 12 months ending September 09, 2018 was $-1m a -45.43% increase of 1m year over year
  • Aquestive Therapeutics Inc Annual Capital Expenditures for 2017 was $-2m a 52.80% decrease of -1m from 2016
  • Aquestive Therapeutics Inc Annual Capital Expenditures for 2016 was $-1m a -246.11% increase of 2m from 2015
  • Aquestive Therapeutics Inc Annual Capital Expenditures for 2006 was $-3m a 18.27% decrease of -1m from 2005
Other Cash Flow Metrics:
  • Aquestive Therapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-11m a 35.43% decrease of -4m year over year
  • Aquestive Therapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-6m a 59.44% decrease of -4m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Capital Expenditures Data

09/2018$0m
06/2018$-1m
03/2018$0m
12/2017$0m
09/2017$0m
06/2017$-1m
03/2017$-1m
06/2007$0m
03/2007$-1m
12/2006$-1m

Annual AQST Capital Expenditures Data

2017$-2m
2016$-1m
2006$-3m
2005$-3m
2004$-1m